Skip to Main Content

Paper Details

Cardiometabolic Consequences of Targeted Anticancer Therapies.
J Cardiovasc Pharmacol
3
2022
Akt, CMD, Cardiometabolic disease, PI3K, Patients, anti, cancer, cardiovascular disease, diabetes, dyslipidemia, hyperglycemia, hypertension, mTOR, metabolic syndrome, obesity, patients, tyrosine, tyrosine kinase
Author NameAffiliation
Richard K ChengUniversity of Washington
Neal L WeintraubAugusta University
Neal L WeintraubAugusta University
Neeraj AgarwalHuntsman Cancer Institute, University of Utah (NCI-CCC)
  • 1 - 4

Datasets

Release 1.2